University of Wisconsin-American Family Children's Hospital
Pediatric Hematology & Oncology
Dr. Kenneth B. Desantes, MD
|
|
Give Review
Dr. Kenneth B. Desantes practices Pediatric Hematology & Oncology. He graduated from New York Medical College. Kenneth Desantes is a published MD. He has 20 publications published. The most current publication "Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma."
Publications
- NK Cell-based Immunotherapies in Pediatric Oncology.
- KIR receptor-ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cells.
- Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.
- Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.
- Unrelated donor bone marrow transplantation for children with Acute myeloid leukemia beyond first remission or refractory to chemotherapy.
- Successful treatment of an infant with constitutional chromosomal abnormality and hemangiopericytoma with chemotherapy alone.
- Newborn Screening for Severe Combined Immunodeficiency; The Wisconsin Experience (2008-2011).
- Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant Disorders and CML.
- Pleasant memories: remembering immune protection while forgetting about Graft-versus-host disease.
- Bone marrow transplantation for T-B- severe combined immunodeficiency Disease in Athabascan-speaking native Americans.
- An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for Leukemia or genetic disease.
- Autoimmune hemolytic Anemia in patients with SCID after T cell-depleted BM and PBSC transplantation.
- EnGraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.
- Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.
- Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation.
- Bone marrow transplantation in Fanconi Anemia using matched sibling donors.
- Renal transplantation without Chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation.
- Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores.
- Severe intravascular hemolysis in an infant with cyanotic congenital heart Disease: resolution of hemolysis after repair.
Schools
New York Medical College
University Of Wa School Of Med
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
University of Washington -
Children's Hospital of Los Angeles -
New York Medical College
Hospital
-
Meriter UnityPoint Health -
University of Wisconsin Hospital and Clinics
Helpful Reviews
Similar Doctors
|
|
Dr. Paul M. Sondel, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Christian M. Capitini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane M. Puccetti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul F. Dvorak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mario Otto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sinisa Dovat, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rachel E. Ershler, MD
This Doctor is OpenDoctor Recommended.
|